A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania

ConditionBreast Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMemorial Sloan Kettering Cancer Center

About this trial

The purpose of this study is to learn more about the challenges with breast cancer diagnosis in Tanzania and the support available to improve this process.

Eligibility criteria

Qualifiers

Breast cancer survivor, patient advocate or key healthcare personnel

>12 months of employment at the affiliated institution

Administrative or clinical involvement in the delivery of breast cancer care services.

Age 18 years and above

Disqualifiers

Key stakeholder not residing at their particular institutions during data collection will be excluded.

Age 18 years and above

Permanent residents or citizens of Tanzania

Received breast cancer diagnosis

Trial design

Treatments tested in this trial

  • Focus group
  • Organizational Readiness for Implementing Change

Treatment groups

85 Participants
are divided into 1 treatment group